The combined effect of 5-fluorocytosine and amphotericin B in the therapy of murine cryptococcosis.
D000666:Amphotericin B / Q000008:administration & dosage* / Q000494:pharmacology / Q000627:therapeutic use; D000818:Animals; D000935:Antifungal Agents / Q000008:administration & dosage*; D003453:Cryptococcosis / Q000188:drug therapy* / Q000382:microbiology / Q000401:mortality; D003455:Cryptococcus neoformans / Q000187:drug effects / Q000302:isolation & purification; D003596:Cytosine / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D004352:Drug Resistance, Microbial; D004357:Drug Synergism; D005437:Flucytosine / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D007274:Injections, Intraperitoneal; D007275:Injections, Intravenous; D051379:Mice; D008826:Microbial Sensitivity Tests
D000935:Antifungal Agents; D000666:Amphotericin B; D003596:Cytosine; D005437:Flucytosine